POSTER 17

Patients Maintain Stable Response with No or Minimal Fluctuations during 3 Years of Continuous Treatment with Lebrikizumab during Long-Term Extension Trial

Jonathan I. Silverberg, Linda Stein Gold, Peter Lio, James Del Rosso, Andreas Wollenberg, Jose Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Helena Agell, Christian Vestergaard

< Previous Poster | Next Poster >

Poster 17